CEACAM5 and colorectal cancer: The authors discovered that intraoperative chemotherapy showed no significant extra prognostic benefit in total colorectal cancer patients who underwent radical surgical resection; however, in colon cancer patients with abnormal pretreatment serum CEA (carcinoembryonic antigen) levels, intraoperative chemotherapy could improve long-term survival.